Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the […]
LovedBy and Dexcom Announce Partnership to Help Adolescent Diabetes Patients
LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]
CYTENA Launches C.STATION, a Fully Automated Platform for Stable Cell Line Development to Streamline Production of Antibody and Gene Therapies
Today CYTENA, a BICO company, launched C.STATION, a new platform for fully automated stable cell line development. The […]
EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access, Channel and Patient Services
EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced […]
New Technique Makes Heart Transplant Possible for More Children in Need
A new technique developed by researchers BHF funded at Great Ormond Street Hospital for Children […]
PerkinElmer Launches Next-generation Cell Image Analysis and Management Software to Streamline Drug Discovery Decision-making
PerkinElmer, Inc., a global leading solutions provider in the life sciences, diagnostics, food and environmental […]
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Certain People with Early Non-small Cell Lung Cancer
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration […]
H.E.L Group Releases Latest Update to LabCONSOL Automation Software with Enhanced Calibration and Process Safety Functionality
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, […]
Applied BioMath, LLC Announces Collaboration with BYOMass™ for Systems Pharmacology Modeling in Oncology
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis […]
NHS Delivers Over Three Million COVID Boosters in First Month
More than three million top up COVID-19 jabs have been delivered in just four weeks, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more